102035-37-0 Usage
Molar mass
173.21 g/mol
The mass of one mole of 2,3-Dihydro-5-methoxy-1H-indene-1-carbonitrile is 173.21 grams.
Nitrile derivative
Indene
The compound is derived from indene, an aromatic hydrocarbon, by attaching a carbonitrile group to the ring.
Carbonitrile group
Cyano functional group (-CN)
A cyano group is present in the structure, which is a cyanide ion (CN-) attached to an organic molecule.
Methoxy group
Methoxy functional group (-OCH3)
A methoxy group is present in the structure, which is a methoxy functional group (-OCH3) attached to the aromatic ring.
Usage
Intermediate in synthesis
2,3-Dihydro-5-methoxy-1H-indene-1-carbonitrile is commonly used as an intermediate in the synthesis of various pharmaceuticals and organic compounds.
Biological activities
Anti-inflammatory and antifungal properties
The compound has potential biological activities, including the ability to reduce inflammation and inhibit the growth of fungi.
Application
Research and development of new drugs
2,3-Dihydro-5-methoxy-1H-indene-1-carbonitrile is utilized in the research and development of new drugs due to its unique properties.
Building block
Creation of new molecules
The compound serves as a building block in chemical research for the creation of new molecules with unique properties.
Check Digit Verification of cas no
The CAS Registry Mumber 102035-37-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,2,0,3 and 5 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 102035-37:
(8*1)+(7*0)+(6*2)+(5*0)+(4*3)+(3*5)+(2*3)+(1*7)=60
60 % 10 = 0
So 102035-37-0 is a valid CAS Registry Number.
102035-37-0Relevant articles and documents
6-SUBSTITUTED NICOTINAMIDE DERIVATIVES AS OPIOID RECEPTOR ANTAGONISTS
-
Page 52, (2008/06/13)
A compound of the formula (I) or a pharmaceutically acceptable salt, enantiomer, racemate, diastereomers or mixtures thereof, or a solvate thereof, formulations and methods of use thereof, as opioid receptor antagonists are disclosed wherein the variables are as described herein.
